Inhibitory Antibodies
-
F2020 Anti-Integrin b7/ITGB7 Antibody (Genentech patent anti-Integrin β7)Summary: Anti-Integrin b7/ITGB7 Antibody (Genentech patent anti-Integrin β7) -
F2021 Anti-KAAG1 Antibody (ADCT-901)Summary: Anti-KAAG1 Antibody (ADCT-901) -
F2022 Anti-BACE1 Antibody (Genentech anti-BACE1)Summary: Anti-BACE1 Antibody (Genentech anti-BACE1) -
F2023 Anti-CTSS/Cathepsin S Antibody (Fsn0503h)Summary: Anti-CTSS/Cathepsin S Antibody (Fsn0503h) -
F2024 Anti-ACVR1/ALK-2 Antibody (DS-6016a)Summary: Anti-ACVR1/ALK-2 Antibody (DS-6016a) -
F2025 Anti-RGMA Antibody (Elezanumab)Summary: Anti-RGMA Antibody (Elezanumab) -
F2026 Anti-FZD Antibody (Vantictumab)Summary: Anti-FZD Antibody (Vantictumab) -
F2027 Anti-LRRC32/TGFβ1 Antibody (Livmoniplimab)Summary: Anti-LRRC32/TGFβ1 Antibody (Livmoniplimab) -
F2028 Anti-TGFb1 Antibody (NIS793)Summary: Anti-TGFb1 Antibody (NIS793) -
F2029 Anti-GFRA3 Antibody (Nadecnemab)Summary: Anti-GFRA3 Antibody (Nadecnemab)

